AMAG Pharma (AMAG) Reports Q3 Loss of $4.31/Share
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total costs and expenses: 105.02M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of ($4.31), may not compare to the analyst estimate of $0.18. Revenue for the quarter came in at $153.7 million versus the consensus estimate of $168.69 million.
GUIDANCE:
AMAG Pharma sees FY2017 revenue of $596-628 million, versus the consensus of $652 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
